Institutional Fund
Ra Capital Management, L.P.
Boston, MACIK 13468245 filings on record
Portfolio Value
$9.44B
Q1 2026
Holdings
85
Reported positions
New Buys
24
Opened this quarter
QoQ Change
-3.3%
from $9.76B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Ascendis Pharma A/S24.9%
- Vaxcyte Inc7.1%
- Rhythm Pharmaceuticals Inc6.1%
- Tyra Biosciences Inc5.0%
- Sionna Therapeutics Inc4.2%
- Edgewise Therapeutics Inc3.5%
- Other49.2%
Portfolio Holdings
85 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Ascendis Pharma A/S | 10.28M | $2.35B | 24.9% | 0 | Held |
| 2 | Vaxcyte Inc | 11.47M | $666.79M | 7.1% | +750.0K | Added |
| 3 | Rhythm Pharmaceuticals Inc | 6.67M | $579.81M | 6.1% | 0 | Held |
| 4 | Tyra Biosciences Inc | 12.20M | $467.21M | 5.0% | 0 | Held |
| 5 | Sionna Therapeutics Inc | 9.91M | $397.09M | 4.2% | 0 | Held |
| 6 | Edgewise Therapeutics Inc | 10.43M | $328.50M | 3.5% | 0 | Held |
| 7 | Newamsterdam Pharma Company | 9.55M | $305.70M | 3.2% | 0 | Held |
| 8 | Nuvalent Inc | 2.53M | $259.62M | 2.8% | +654.1K | Added |
| 9 | Dianthus Therapeutics Inc | 2.61M | $219.18M | 2.3% | +1.00M | Added |
| 10 | Mineralys Therapeutics Inc | 7.69M | $208.40M | 2.2% | +369.0K | Added |
75 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio